Tagrisso Tablet (Osimertinib)
Tagrisso (Osimertinib) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) designed to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations. It is particularly effective against the T790M mutation, which often develops after initial EGFR TKI therapy.
Tagrisso (Osimertinib) 80 mg Tablet is a prescription medication used in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations, including the resistant T790M mutation. This advanced, third-generation EGFR tyrosine kinase inhibitor works by blocking abnormal signaling pathways that lead to cancer cell growth.
Tagrisso is known for its high efficacy, targeted action, and favorable tolerability in patients who have previously been treated with first- or second-generation EGFR inhibitors. It is an FDA-approved therapy and is recommended as a first-line treatment for eligible patients with EGFR-mutated NSCLC.
Whether you're starting treatment or continuing after previous therapy, you can buy Osimertinib tablet online through our trusted pharmacy platform. We ensure genuine products, global shipping, and affordable pricing, all with the convenience of home delivery.
Precautions of Tagrisso Tablet:
Pregnancy: Tagrisso may harm an unborn baby. Avoid pregnancy during treatment.
Breastfeeding: Not recommended during treatment and for 2 weeks after the final dose.
Heart Health: Monitor for signs of heart issues, especially if you have a history of cardiac conditions.
Lung Health: Be vigilant for new or worsening respiratory symptoms.
Uses of Tagrisso Tablet:
Tagrisso is indicated for:
First-line treatment of metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R mutations.
Treatment of metastatic EGFR T790M mutation-positive NSCLC in patients who have progressed on or after EGFR TKI therapy.
Side Effects of Tagrisso Tablet:
Common Side Effects:
Diarrhea
Rash
Dry skin
Nail toxicity
Fatigue
Decreased appetite
Mouth sores
Serious Side Effects:
Interstitial lung disease (ILD)
QT interval prolongation
Cardiomyopathy
Keratitis
Severe cutaneous adverse reactions
Seek immediate medical attention if you experience any severe side effects.
FAQs of Tagrisso Tablet:
Q1: How should I take Tagrisso?
Take one 80 mg tablet orally once daily, with or without food. Swallow the tablet whole; do not crush or split.
Q2: What if I miss a dose?
If you miss a dose, take it as soon as you remember. If it's less than 12 hours until your next dose, skip the missed dose. Do not take two doses at the same time.
Q3: Can I buy Osimertinib tablets online?
Yes, you can purchase Osimertinib tablets online through reputable pharmacies. Ensure the pharmacy requires a valid prescription and offers secure payment options.
Interactions of Tagrisso Tablet:
Osimertinib may interact with:
CYP3A4 inducers (e.g., rifampin, phenytoin): May decrease osimertinib effectiveness.
CYP3A4 inhibitors (e.g., ketoconazole): May increase osimertinib levels and risk of toxicity.
Drugs prolonging QT interval (e.g., amiodarone): May increase risk of cardiac arrhythmias.
Always inform your healthcare provider about all medications and supplements you are taking.
| Manufacturer | : | AstraZeneca, India |
| Trade Name | : | |
| Generic Search | : | Osimertinib |
| Strength | : | 40mg, 80mg |
Latest Products
